A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Bio Green Med Solution, Inc.
BGMS
$5M
Mkt Cap
$0.92
+3.98%
Bio Green Med Solution, Inc. (BGMS) has a 5-year average return on invested capital (ROIC) of -124.2%. This is below average and may indicate limited pricing power.
Bio Green Med Solution, Inc. (BGMS) has a market capitalization of $5M. It is classified as a small-cap stock.
Yes, Bio Green Med Solution, Inc. (BGMS) pays a dividend with a trailing twelve-month yield of 1.23%.
Bio Green Med Solution, Inc. (BGMS) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
Bio Green Med Solution, Inc. (BGMS) generated $-5 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Bio Green Med Solution, Inc. (BGMS) has a debt-to-equity ratio of 0.00. This indicates a conservatively financed balance sheet.
Bio Green Med Solution, Inc. (BGMS) reported earnings per share (EPS) of $-2.61 in its most recent fiscal year.
Item 1. Business The following Business Section contains forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain risks, uncertainties and other factors including the risk factors set forth in Part I, Item 1A of this Annual Report on Form 10-K. In this report, “Cyclacel,” the “Company,” “we,” “us,” and “our” refer to Cyclacel Pharmaceuticals, Inc. In December 2024 the Company announced that it was in the process of exploring and reviewing strategic alternatives on an expedited basis in order to preserve the Company’s cash, including a potential transaction with investor David Lazar of Activist Investing, LLC, or “Lazar”. The Company’s Board of Directors reviewed a range of appropriate strategies to realize value from its assets.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 43K | 420K | 0 | 0 |
| Net Income | -14M | -14M | - | - | - | -18M |
| EPS | $-2.61 | $-2.61 | $-279,618.99 | $-1,540,603.20 | $-98,064.00 | $-7,524.00 |
| Free Cash Flow | -4.8M | -4.8M | -8.0M | -16M | -21M | -19M |
| ROIC | -199.4% | -199.4% | - | - | - | -49.0% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.00 | -2.88 | 0.06 | 0.01 | 0.00 |
| Dividends/Share | $0.01 | $0.01 | - | $55.84 | $548.91 | $81.94 |
| Operating Income | -8.4M | -8.4M | -12M | -25M | -28M | -22M |
| Operating Margin | 0.0% | - | -27916.3% | -6060.2% | - | - |
| ROE | -206.0% | -206.0% | - | - | - | -49.0% |
| Shares Outstanding | 5M | 5M | 0M | 0M | 0M | 0M |
| Metric | 2018 | 2019 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | N/A | N/A | N/A | 0 | N/A | 150K | 0 | 0 | 0 | 420K | 43K | 0 | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | 18M | 12M | 9.5M | 4.2M | 4.3M | 4.7M | 4.8M | 15M | 20M | 19M | 6.7M | 848K | 848K |
| SG&A | 5.9M | 5.7M | 5.5M | 5.3M | 5.4M | 5.0M | 5.9M | 7.5M | 7.4M | 6.7M | 5.4M | 7.7M | 7.7M |
| EBIT | -22M | -16M | -14M | -9.5M | -9.5M | -9.7M | -11M | -22M | -28M | -25M | -12M | -8.4M | -8.4M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | -6454.7% | N/A | N/A | N/A | -6060.2% | -27916.3% | N/A | 0.0% |
| Net Income | -20M | -15M | -12M | -7.5M | -7.3M | N/A | -8.4M | -18M | N/A | N/A | N/A | -14M | -14M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | -78.2% | -71.8% | -72.4% | -41.5% | -47.7% | N/A | -25.4% | -49.0% | N/A | N/A | N/A | -199.4% | -199.4% |
| ROE | -78.8% | -71.8% | -72.4% | -41.5% | -39.4% | N/A | -25.4% | -49.0% | N/A | N/A | N/A | -206.0% | -206.0% |
| ROA | -60.4% | -53.7% | -54.0% | -32.7% | -31.8% | N/A | -22.9% | -42.8% | N/A | N/A | N/A | -229.5% | -172.2% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -19M | -14M | -10M | -7.5M | -6.7M | -9.4M | -7.9M | -19M | -21M | -16M | -8.0M | -4.8M | -4.8M |
| Free Cash Flow | -19M | -14M | -10M | -7.5M | -6.7M | -9.5M | -8.0M | -19M | -21M | -16M | -8.0M | -4.8M | -4.8M |
| Owner Earnings | -20M | -15M | -11M | -40M | -7.1M | -9.9M | -8.4M | -20M | -22M | -18M | -8.6M | -7.1M | -7.1M |
| CapEx | 309K | 34K | 3K | 13K | 39K | 10K | 96K | 27K | 7K | 6K | 0 | 0 | 0 |
| Maint. CapEx | 200K | 200K | 100K | 32M | 29K | 20K | 20K | 43K | 32K | 31K | 6K | 5K | 5K |
| Growth CapEx | 109K | 0 | 0 | 0 | 10K | 0 | 76K | 0 | 0 | 0 | N/A | N/A | 0 |
| D&A | 200K | 200K | 100K | 32M | 29K | 20K | 20K | 43K | 32K | 31K | 6K | 5K | 5K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 200K | 201K | 200K | 201K | 201K | 201K | 201K | 201K | 201K | 201K | 0 | 61K | 61K |
| Dividend Yield | N/A | N/A | N/A | N/A | 0.0% | N/A | 0.6% | 0.8% | 16.6% | 5.5% | N/A | N/A | 1.2% |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | N/A | 0.0% | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 1.2M | 745K | 782K | 266K | 331K | 466K | 430K | 1.2M | 1.5M | 1.5M | 592K | 2.3M | 2.3M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | N/A | N/A | N/A | N/A | N/A | -23M | -66M | -73M | -37M | -6.7M | N/A | -3.5M | -3.5M |
| Cash & Equiv. | 24M | 20M | 17M | 24M | 18M | 12M | 33M | 37M | 18M | 3.4M | 3.1M | 3.5M | 3.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2K |
| Debt/Equity | 0.35 | 0.31 | 0.38 | 0.19 | 0.30 | 0.10 | 0.03 | 0.00 | 0.01 | 0.06 | -2.88 | 0.00 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | -80.4 | -28.8 | N/A | N/A | N/A | N/A | N/A | -1000.3 | -135.9 | -135.9 |
| Equity | 22M | 19M | 14M | 22M | 15M | 12M | 33M | 38M | 16M | 607K | -2.2M | 6.8M | 6.8M |
| Total Assets | 29M | 25M | 20M | 26M | 20M | 15M | 37M | 43M | 28M | 8.8M | 4.1M | 8.2M | 8.2M |
| Total Liabilities | 7.7M | 5.9M | 5.4M | 4.2M | 4.6M | 3.6M | 3.5M | 5.4M | 7.6M | 8.2M | 6.3M | 1.3M | 1.3M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 0 |
| Retained Earnings | -309M | -323M | -335M | -343M | -350M | -358M | -366M | -385M | -406M | -428M | -439M | -454M | -454M |
| Working Capital | 22M | 19M | 14M | 22M | 15M | 12M | 33M | 36M | 17M | -717K | -2.6M | 4.9M | 4.9M |
| Current Assets | 29M | 25M | 20M | 26M | 20M | 14M | 35M | 41M | 24M | 7.4M | 3.7M | 6.3M | 6.3M |
| Current Liabilities | 7.5M | 5.8M | 5.3M | 4.1M | 4.5M | 2.4M | 2.5M | 5.4M | 7.5M | 8.2M | 6.3M | 1.3M | 1.3M |
| Per Share Data | |||||||||||||
| EPS | -26,415.20 | -159,084.80 | -8,656.67 | -4,619.93 | -148.80 | -708,480.00 | -12,312.00 | -7,524.00 | -98,064.00 | -1,540,603.20 | -279,618.99 | -2.61 | -2.61 |
| Owner EPS | -27,140.75 | -168,514.15 | -7,913.08 | -24,581.51 | -144.17 | -100,677.26 | -3,020.31 | -8,047.02 | -61,076.10 | -4,893.89 | -129,472.60 | -1.32 | -1.32 |
| Book Value | 29,248.63 | 206,034.67 | 10,304.11 | 13,461.51 | 311.81 | 118,556.52 | 11,981.47 | 15,365.56 | 43,527.48 | 168.63 | -32,775.20 | 1.27 | 1.27 |
| Cash Flow/Share | -25,221.68 | -158,176.87 | -7,276.34 | -4,626.12 | -136.82 | -95,751.34 | -2,858.20 | -7,557.83 | -56,876.01 | -4,476.07 | -120,457.16 | -0.88 | -2.61 |
| Dividends/Share | 269.72 | 2,198.72 | 144.39 | 124.31 | 4.10 | 2,037.26 | 72.41 | 81.94 | 548.91 | 55.84 | N/A | 0.01 | 0.01 |
| Shares Out. | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 5.4M | 5.4M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.4 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | 0.2 | N/A | 1.3 | 0.4 | 0.3 | 468.3 | N/A | N/A | 0.7 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A | N/A | -194.7% | N/A | -18.6% | -113.7% | -404.2% | -5.7% | -22.8% | N/A | -96.5% |
| Market Cap | 0 | 0 | 0 | 0 | 3.5M | 0 | 43M | 16M | 5.2M | 284M | 35M | 0 | 4.9M |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.00 | 49,248.27 | 0.00 | 11,262.48 | 10,707.58 | 3,311.48 | 1,014.73 | 184.79 | 0.00 | 0.92 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.00 | 21,202.76 | 0.00 | 15,519.72 | 6,656.28 | 938.48 | 329.05 | 40.55 | 0.00 | 0.92 |
Bio Green Med Solution, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
Total shareholder yield (dividends) is 1.2%.
Bio Green Med Solution, Inc. (BGMS) has a return on equity (ROE) of -206.0%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 17 years of financial data for Bio Green Med Solution, Inc. (BGMS), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Bio Green Med Solution, Inc. (BGMS) has a book value per share of $1.27, based on its most recent annual SEC filing.